Evolocumab-Induced Angioedema

Future cases should focus on exploring immunological mechanisms underlying this adverse effect. Immune profiling may help identify patients at higher risk of evolocumab-induced angioedema.

Authors

Institutions

Publication Details

Journal
JACC Case Reports
Published
2026-01-13
DOI
https://doi.org/10.1016/j.jaccas.2025.106730
Citations
1
Primary Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
36.93
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolocumab-Induced Angioedema

Sergey Kachur, Paula Derias, Bola Habeb, John Retzloff
1 citations
JACC Case Reports
Coagulation, Bradykinin, Polyphosphates, and Angioedema
36.93
article

Evolocumab-Induced Angioedema

Sergey Kachur, Paula Derias, Bola Habeb, John Retzloff
article en
1 citations

Abstract

Future cases should focus on exploring immunological mechanisms underlying this adverse effect. Immune profiling may help identify patients at higher risk of evolocumab-induced angioedema.

JACC Case ReportsVol. 31(9)
University Hospitals Coventry and Warwickshire NHS Trust (GB), Sacred Heart Hospital (US), Sacred Heart Health System (US)
Openalex Percentile: Top 1%
Coagulation, Bradykinin, Polyphosphates, and Angioedema
36.93
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.